The AstraZeneca vaccine has been found to be highly effective in preventing severe illness and death from Covid-19. However, there have been concerns raised about the risk of blood clots occurring after vaccination. Despite these concerns, experts have stated that the risk is extremely rare, typically occurring within 42 days of vaccination.
In light of these concerns, the Director of the Department of Health in Ho Chi Minh City, Tang Chi Thuong, has reassured the public that blood clots are a rare side effect of the Covid-19 vaccine and can be effectively treated. He urged people not to fear receiving the vaccine, emphasizing its importance in protecting against severe illness and death from Covid-19. Doctor Truong Huu Khanh, Vice President of the Ho Chi Minh City Association of Infectious Diseases, echoed this sentiment, explaining that blood clotting issues can arise in various clinical situations, including Covid-19 infection, and are not solely linked to vaccination.
The European Medicines Agency has recommended the continued use of the AstraZeneca vaccine, highlighting the importance of consultation, detection, and treatment of possible complications that may arise. In light of AstraZeneca’s acknowledgment of potential blood clotting side effects, experts believe that this recognition will guide future vaccine research and development, prompting closer attention to potential adverse effects in future vaccination efforts. Despite these acknowledgments
